FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileOptiscan Imaging Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OIL.AX
Optiscan Imaging Limited Stock AnalysisComprehensive stock analysis for Optiscan Imaging Limited (OIL.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisOIL.AX
OIL.AX
Optiscan Imaging Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OIL.AX
  1. Home
  2. Stocks
  3. Optiscan Imaging Limited

Optiscan Imaging Limited

🇦🇺OIL.AX•ASX

Optiscan Imaging Limited

🇦🇺OIL.AX•ASX

Your view on OIL.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Optiscan Imaging Limited

Industry
Medical - Specialties
Sector
Healthcare
CEO
Camile Farah
Headquarters
16 Miles St, Mulgrave, VIC, AU
Industry
Medical - Specialties
Sector
Healthcare
CEO
Camile Farah
Headquarters
16 Miles St, Mulgrave, VIC, AU
Description

Optiscan Imaging Limited specializes in the development and market introduction of confocal microscopy technology, applied across both clinical and pre-clinical settings in Australia, Germany, and other global regions.

A notable offering is the FIVE2 (ViewnVivo) system, a compact confocal endomicroscope utilized for a broad range of research, including clinical, translational, and pre-clinical studies. Additionally, the company is actively developing the InVivage device, which is intended for use in cancer screening and surgical procedures.

Established in 1994, Optiscan Imaging Limited maintains its headquarters in Mulgrave, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Optiscan Imaging Limited. Starting points for Optiscan Imaging Limited: EPS -AUD 0.0067, beta 0.10 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Optiscan Imaging Limited. Optiscan Imaging Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Optiscan Imaging Limited. Trailing twelve-month EPS for Optiscan Imaging Limited stands at -AUD 0.0067. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · AUD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent YearFY Jun 2001
Avg. estimateAUD 0.01
Low estimate−AUD 0.00
High estimateAUD 0.01
No. of analysts3
Year-ago EPS—
Growth—

Revenue Estimate

RevenueCurrent YearFY Jun 2001
Avg. estimateAUD 8.42M
Low estimateAUD 3.84M
High estimateAUD 12.88M
No. of analysts3
Year-ago revenue—
Growth—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Optiscan Imaging Limited. Optiscan Imaging Limited has reported as a listed company since 1997. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold OIL.AX17 companies
Compare OIL.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
4DX.AX4DMedical LimitedHealthcareMedical - Devices—
CMP.AXCompumedics LimitedHealthcareMedical - Devices—
EMV.AXEMVision Medical Devices LtdHealthcareMedical - Devices—
IBX.AXImagion Biosystems LimitedHealthcareMedical - Diagnostics & Research—
MX1.AXMicro-X LimitedHealthcareMedical - Devices—
More Medical - Specialties companies
TickerTypeCompanySectorExchangeMkt cap
SSMXYSysmex CorporationHealthcareOTC$5.5B
STESTERIS plcHealthcareNYSE$25.2B
TRIBTrinity Biotech plcHealthcareNASDAQ$118.0M
UAHCUnited American Healthcare CorporationHealthcareOTC$1.1M
UEECUnited Health Products, Inc.HealthcareOTC$14.9M
VFY.AXVitrafy Life Sciences Ltd.HealthcareASX—
VMTHFVenus Medtech (Hangzhou) Inc.HealthcareOTC$184.7M
VVVVvVARDIS HOLDING AG Class AHealthcareNYSE$597.1M
WCUIWellness Center USA, Inc.HealthcareOTC$13,063
WOKWORK Medical Technology Group Ltd.HealthcareNASDAQ$5.1M
YPHDFYpsomed Holding AGHealthcareOTC$5.2B
ACAISafeplus International Holdings LimitedHealthcareOTC$477
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Optiscan Imaging Limited. Coverage tracks Optiscan Imaging Limited within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Optiscan Imaging Limited.

OIL.AX AnalysisFair
Past
3
Growth
1
Health
5
Profit
1
Value
1

News

Latest Market News